Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets
- PMID: 24089569
- PMCID: PMC3838242
- DOI: 10.1128/JVI.02434-13
Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets
Abstract
Influenza H3N2 A viruses continue to circulate in swine and occasionally infect humans, resulting in outbreaks of variant influenza H3N2 [A(H3N2)v] virus. It has been previously demonstrated in ferrets that A(H3N2)v viruses transmit as efficiently as seasonal influenza viruses, raising concern over the pandemic potential of these viruses. However, A(H3N2)v viruses have not acquired the ability to transmit efficiently among humans, which may be due in part to existing cross-reactive immunity to A(H3N2)v viruses. Although current seasonal H3N2 and A(H3N2)v viruses are antigenically distinct from one another, historical H3N2 viruses have some antigenic similarity to A(H3N2)v viruses and previous exposure to these viruses may provide a measure of immune protection sufficient to dampen A(H3N2)v virus transmission. Here, we evaluated whether prior seasonal H3N2 influenza virus vaccination or infection affects virus replication and transmission of A(H3N2)v virus in the ferret animal model. We found that the seasonal trivalent inactivated influenza virus vaccine (TIV) or a monovalent vaccine prepared from an antigenically related 1992 seasonal influenza H3N2 (A/Beijing/32/1992) virus failed to substantially reduce A(H3N2)v (A/Indiana/08/2011) virus shedding and subsequent transmission to naive hosts. Conversely, ferrets primed by seasonal H3N2 virus infection displayed reduced A(H3N2)v virus shedding following challenge, which blunted transmission to naive ferrets. A higher level of specific IgG and IgA antibody titers detected among infected versus vaccinated ferrets was associated with the degree of protection offered by seasonal H3N2 virus infection. The data demonstrate in ferrets that the efficiency of A(H3N2)v transmission is disrupted by preexisting immunity induced by seasonal H3N2 virus infection.
Figures
Similar articles
-
Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.J Virol. 2019 Jan 17;93(3):e00946-18. doi: 10.1128/JVI.00946-18. Print 2019 Feb 1. J Virol. 2019. PMID: 30429350 Free PMC article.
-
Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.Influenza Other Respir Viruses. 2011 Jan;5(1):13-23. doi: 10.1111/j.1750-2659.2010.00177.x. Epub 2010 Nov 3. Influenza Other Respir Viruses. 2011. PMID: 21138536 Free PMC article.
-
Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity.Vaccine. 2018 Aug 9;36(33):5097-5103. doi: 10.1016/j.vaccine.2018.06.053. Epub 2018 Jul 13. Vaccine. 2018. PMID: 30007825 Free PMC article.
-
Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015.Vaccine. 2017 Feb 22;35(8):1104-1109. doi: 10.1016/j.vaccine.2017.01.018. Epub 2017 Jan 25. Vaccine. 2017. PMID: 28131392 Free PMC article. Review.
-
Improving immunological insights into the ferret model of human viral infectious disease.Influenza Other Respir Viruses. 2019 Nov;13(6):535-546. doi: 10.1111/irv.12687. Epub 2019 Oct 3. Influenza Other Respir Viruses. 2019. PMID: 31583825 Free PMC article. Review.
Cited by
-
Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.J Virol. 2022 Apr 13;96(7):e0165221. doi: 10.1128/jvi.01652-21. Epub 2022 Mar 15. J Virol. 2022. PMID: 35289635 Free PMC article.
-
Ferrets as a Mammalian Model to Study Influenza Virus-Bacteria Interactions.J Infect Dis. 2024 Feb 14;229(2):608-615. doi: 10.1093/infdis/jiad408. J Infect Dis. 2024. PMID: 37739789
-
Establishment of a mouse- and egg-adapted strain for the evaluation of vaccine potency against H3N2 variant influenza virus in mice.J Vet Med Sci. 2021 Oct 31;83(11):1694-1701. doi: 10.1292/jvms.21-0350. Epub 2021 Sep 14. J Vet Med Sci. 2021. PMID: 34526415 Free PMC article.
-
Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera.Clin Infect Dis. 2017 Jul 15;65(2):259-267. doi: 10.1093/cid/cix269. Clin Infect Dis. 2017. PMID: 28369230 Free PMC article.
-
Adaptation of Human Influenza Viruses to Swine.Front Vet Sci. 2019 Jan 22;5:347. doi: 10.3389/fvets.2018.00347. eCollection 2018. Front Vet Sci. 2019. PMID: 30723723 Free PMC article. Review.
References
-
- CDC 5 July 2013, posting date. Case count: detected U.S. human infections with H3N2v by state since August 2011. Centers for Disease Control and Prevention, Atlanta, GA: http://www.cdc.gov/flu/swineflu/h3n2v-case-count.htm
-
- Vincent AL, Ma W, Lager KM, Janke BH, Richt JA. 2008. Swine influenza viruses a North American perspective. Adv. Virus Res. 72:127–154 - PubMed
-
- Shu B, Garten R, Emery S, Balish A, Cooper L, Sessions W, Deyde V, Smith C, Berman L, Klimov A, Lindstrom S, Xu X. 2012. Genetic analysis and antigenic characterization of swine origin influenza viruses isolated from humans in the United States, 1990-2010. Virology 422:151–160 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous